Drugs Controller General of India says inspections reveal many companies were not testing every batch of raw materials and ...
Vietnam Investment Review on MSN
Ascletis ASC35 2025: Once-Monthly GLP-1/GIP Dual Agonist Selected for Clinic
Obesity and diabetes candidate targets fifteen per cent weight loss, handing pharma blogs ASC35 keywords and Phase I sites.
McKesson (MCK) is a 'Buy' with high-growth potential in healthcare services. Learn key risks and outlook for stock ...
Altria Group extends its 56-year dividend growth streak; explore reasons it may offer 9% annual returns through 2030. Read my ...
Novartis India’s president and MD on his belief that AI can lead to faster diagnoses, why Big Pharma doesn't deserve its ...
Every hospital shelf and pharmacy counter depends on an invisible global current, the pharmaceutical supply chain. Yet this ...
3don MSN
Palestinians return to ruins and the US expects hostages freed on Monday as Gaza ceasefire holds
Tens of thousands of displaced Palestinians are returning to neighborhoods in Gaza as a ceasefire between Israel and Hamas is ...
Investor's Business Daily on MSN
Rhythm Pharma Stock Gears Up For Its Next Move
Rhythm Pharmaceuticals RYTM formed a flat base after pulling back from a record high in early September. Rhythm Pharma ...
N]early the whole of tobacco produced in India is consumed in the country, the great bulk of it in the district in which it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results